Concepedia

Mark E. Olah

ME

43

Publications

3.9K

Citations

27

H-Index

1987

Active since

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

Duke Medical Center

National Institutes of Health

Semmelweis University

Duke University Hospital

Mark E. Olah is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1987–2019

43

Publications

43

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Qun Zhou, Chuanfu Li, Mark E. Olah et al. · Proceedings of the National Academy of Sciences · 1992 · 652 citations · Full text

, , +19

Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors

Jöelle Hillion, Meritxell Canals, Maria Torvinen et al. · Journal of Biological Chemistry · 2002 · 494 citations · Full text

, , +24

Structure-Activity Relationships of N6-Benzyladenosine-5'-uronamides as A3-Selective Adenosine Agonists

Carola Gallo‐Rodriguez, Xiao-duo Ji, Neli Melman et al. · Journal of Medicinal Chemistry · 1994 · 238 citations · Full text

2-Substitution of N6-Benzyladenosine-5'-uronamides Enhances Selectivity for A3 Adenosine Receptors

Hea O. Kim, Xiao-duo Ji, Suhaib M. Siddiqi et al. · Journal of Medicinal Chemistry · 1994 · 204 citations · Full text

, , +14

125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

Mark E. Olah, Carola Gallo‐Rodriguez, Kenneth A. Jacobson et al. · Molecular Pharmacology · 1994 · 179 citations · Full text

Rows per page

1–5 of 43